Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Global | 2014 | Market Analysis

The mature global CRM device market will expand until 2019, primarily driven by favorable demographics and the launch of premium-priced novel devices such as MRI-compatible devices, leadless pacemakers, and S-ICDs. By 2022, the market will undergo a slight decline as price erosion takes place across all segments.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the global cardiac rhythm management device market across a 10-year period.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is projected to grow slightly through 2035, driven by the increasing adoption of innovative devices, particularly extravascular ICDs, and CSP-capable pacing and…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Cardiac Rhythm Management Devices | Market Insights | US | 2026
The US CRM device market is expected to grow rapidly through 2034, driven by the increasing adoption of innovative devices, such as dual-chamber leadless pacemakers and extravascular ICDs…